1-Hydroxy-2(1H)-pyridinone-Based Chelators with Potential Catechol O-Methyl Transferase Inhibition and Neurorescue Dual Action against Parkinson’s Disease

Joseph C.J. Bergin, Kean Kan Tan, Anya K. Nelson, Cristina-Andreea Amarandei, Veronique Hubscher-Bruder, Jeremy Brandel, Varvara Voinarovska, Annick Dejaegere, Roland H. Stote, David Tetard*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Abstract

Two analogues of tolcapone where the nitrocatechol group has been replaced by a 1-hydroxy-2(1H)-pyridinone have been designed and synthesised. These compounds are expected to have a dual mode of action both beneficial against Parkinson’s disease: they are designed to be inhibitors of catechol O-methyl transferase, which contribute to the reduction of dopamine in the brain, and to protect neurons against oxidative damage. To assess whether these compounds are worthy of biological assessment to demonstrate these effects, measurement of their pKa and stability constants for Fe(III), in silico modelling of their potential to inhibit COMT and blood–brain barrier scoring were performed. These results demonstrate that the compounds may indeed have the desired properties, indicating they are indeed promising candidates for further evaluation.
Original languageEnglish
Article number2816
Number of pages20
JournalMolecules
Volume27
Issue number9
DOIs
Publication statusPublished - 28 Apr 2022

Fingerprint

Dive into the research topics of '1-Hydroxy-2(1H)-pyridinone-Based Chelators with Potential Catechol O-Methyl Transferase Inhibition and Neurorescue Dual Action against Parkinson’s Disease'. Together they form a unique fingerprint.

Cite this